Harmony Biosciences Holdings, Inc (HRMY) insider trading
Every open-market stock purchase and sale by Harmony Biosciences Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Kumar Budur (C-suite exec) sold $3.1M in the last 90 days.
- Last insider buy: Jack Nielsen (Director), $135K, 6 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $6M (7 sales). Last close $38.31 on Oct 21, 2026.
Recent HRMY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 18, 2026 | Kumar Budur (C-suite exec) | Sold | $1.5M |
| Sep 18, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Sep 18, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Sep 17, 2026 | Kumar Budur (C-suite exec) | Sold | $34.4K |
| Sep 17, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Sep 16, 2026 | Kumar Budur (C-suite exec) | Sold | $77.4K |
| Sep 16, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Kumar Budur (C-suite exec) | Sold | $989K |
| Sep 8, 2026 | Kumar Budur (C-suite exec) | Sold | $190K |
| Sep 8, 2026 | Kumar Budur (C-suite exec) | Sold | $42.8K |
| Sep 8, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Sep 4, 2026 | Kumar Budur (C-suite exec) | Sold | $231K |
| May 14, 2026 | R. Mark Graf (Insider) | Bought (not open market) | — |
| May 14, 2026 | Juan A. Sabater (Insider) | Bought (not open market) | — |
| May 14, 2026 | Ron M Philip (Insider) | Bought (not open market) | — |
| May 14, 2026 | Linda M Szyper (Insider) | Bought (not open market) | — |
| May 14, 2026 | Gary Sender (Insider) | Bought (not open market) | — |
| May 14, 2026 | Geno J Germano (Insider) | Bought (not open market) | — |
| May 1, 2026 | Kumar Budur (C-suite exec) | Sold (not open market) | $283K |
| May 1, 2026 | Kumar Budur (C-suite exec) | Bought (not open market) | — |
| Apr 14, 2026 | Glenn Reicin (CFO) | Bought (not open market) | — |
| Apr 7, 2026 | Adam H. Zaeske (C-suite exec) | Sold (not open market) | $87.6K |
| Apr 7, 2026 | Adam H. Zaeske (C-suite exec) | Bought (not open market) | — |
| Apr 2, 2026 | Peter Anastasiou (COO) | Bought (not open market) | — |
Who's trading HRMY
- Kumar Budur, C-suite exec: sold $3.1M (7 sales), last Sep 18, 2026
- Ron M Philip, Insider: other filings, last May 14, 2026
- Linda M Szyper, Insider: other filings, last May 14, 2026
- Geno J Germano, Insider: other filings, last May 14, 2026
- Gary Sender, Insider: other filings, last May 14, 2026
- R. Mark Graf, Insider: other filings, last May 14, 2026
- Juan A. Sabater, Insider: other filings, last May 14, 2026
- Glenn Reicin, CFO: other filings, last Apr 14, 2026
- Adam H. Zaeske, C-suite exec: other filings, last Apr 7, 2026
- Peter Anastasiou, Insider: other filings, last Apr 2, 2026
- Troy A. Ignelzi, Insider: other filings, last Apr 2, 2026
- Sandip Kapadia, CFO: sold $1.8M (4 sales), last Jan 26, 2026
- Jeffrey M. Dayno, CEO: sold $1M (2 sales), last Jan 25, 2026
- Andrew Serafin, C-suite exec: other filings, last Jan 25, 2026
Get free alerts when an insider at Harmony Biosciences Holdings, Inc files a new trade →